Use of untested 'Wolverine' peptide backed by US Health Secretary Kennedy on the rise, study finds
New patient records show confirmed BPC-157 use rose 33-fold since 2020 as doctors reported limited evidence and mixed safety concerns.
- U.S. Health Secretary Robert Kennedy has backed the experimental peptide BPC-157, which is rising in use for pain and healing despite lacking human safety data, a new analysis found.
- Consumers often pair the unapproved compound with TB-500 in a popular "Wolverine" stack, sourcing it from gray-market vendors or compounding pharmacies based on social media claims of injury recovery.
- Data analytics firm nference reviewed more than 15 million medical records, identifying 1,039 patients using the peptide, with new users increasingly male and younger, averaging age 49 by 2026.
- While the Food and Drug Administration previously restricted BPC-157 compounding due to safety risks, an agency advisory panel voted in July to allow the practice, encouraged by Kennedy.
- University of Utah researcher Flynn McGuire noted the study lacks standardized data, warning that randomized controlled trials are needed to determine if BPC-157 causes clinically meaningful improvement.
4 Articles
4 Articles
Use of untested 'Wolverine' peptide backed by US Health Secretary Kennedy on the rise, study finds
An experimental peptide backed by U.S. Health Secretary Robert F. Kennedy Jr. and marketed online for pain, healing and performance enhancement is being used for a wide range of ailments despite little safety and efficacy evidence from human studies, a new analysis found.
It is promoted on social media for muscle growth, injury healing, and pain management, but data on its safety and efficacy remain limited. An experimental peptide, BPC-157, which has been endorsed by U.S. Secretary of Health Robert F. Kennedy Jr. and promoted online to treat pain, heal injuries and improve physical performance, is used for a wide range of health problems, despite the fact that there is scant evidence from human studies on its sa…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
